News

Toronto - Psoriasis presentation in childhood marks a stronger genetic component than when the disease onset occurs in adulthook, according to an expert.

Irvine, Calif. - Allergan has announced it has entered an agreement with QLT USA to purchase Aczone (dapsone) Gel 5 percent, according to socalTech.com.

National report - Dermatologists are using third-party bartering agencies to trade their services for services and products - from car repair to advertising.

Pittman, N.J. - The Dermatology Nursing Certification Board (DNCB) is now offering a certification exam for nurse practitioners in dermatology, according to a press release.

National report - The use of biologics is the focus of new psoriasis and psoriatic arthritis management guidelines released by the American Academy of Dermatology (AAD), HealthDay News reports.

Costa Mesa, Calif. - CareCredit, a GE Money Company patient payment program, celebrates the 100,000th doctor to offer the service, according to a press release.

Shanghai, China - Prof. Xuemin Wang has been appointed to the scientific advisory board of Symrise, a global fragrance and flavoring supplier, according to Life PR.

Houston - New research indicates that shingles may be genetic, Reuters reports.

Montreal - Isotretinoin, the active ingredient in the acne drug Accutane (Roche Laboratories), could more than double the risk of depression, according to results of a study reported by Reuters Health.

Skokie, Ill. - Results of a recent study suggest that ustekinumab, a human monoclonal antibody, directed against interleukin 12 and 23 is an effective treatment for moderate to severe psoriasis, Reuters Health reports.

Toronto - A Canadian research team reports that intensity-modulated radiation therapy (IMRT) reduces the incidence of radiation-induced dermatitis, compared to conventional radiation, in women being treated for breast cancer, according to Reuters Health.

Seoul, South Korea - A new study suggests that vitamin C suppresses proliferation of human melanoma cells, Foodconsumer.org reports.

Schaumburg, Ill. - Following an extensive analysis of recent studies done on psoriasis and psoriatic arthritis, the American Academy of Dermatology (AAD) has released new care guidelines for managing the conditions.

Scottsdale, Ariz. - Medicis Pharmaceutical has issued a statement announcing its voluntary recall of lot numbers B080037 and B080038 of the antibiotic Solodyn Extended Release Tablets, 90 mg, 30-count bottles, both of which carry an expiration date of December 2009.

Scottsdale, Ariz. - Medicis Pharmaceutical, based here, has announced that the Food and Drug Administration (FDA) has begun a review of Reloxin, the company’s Botox-like anti-wrinkle injectable, the Arizona Republic reports.

As with any legal or insurance planning, the early bird is richly rewarded. Nowhere in practice planning is this truer than in the Buy-Sell agreement. The reason is not so much economic, but political. If this planning is done before any owner is close to a disability, divorce, retirement, or death, all owners are in the same position relative to each other. That makes the negotiation of a standard deal for all owners a much easier and smoother process. Planning early for a Buy-Sell agreement will truly benefit you, your family and your practice.

The results of recent studies on the value of Vitamin D in warding off serious illnesses are fueling the ongoing debate over the dermatologic community's "official" stance that warns against the dangers of sunlight, from which the body most efficiently acquires Vitamin D.

No one in his right mind would accuse Amy S. Paller, M.D., of sitting idly, letting life pass her by.

Mutual funds are a better investment choice than individual stocks for most people

According to one expert, gene profiling using tape stripping, the MelaFind® device as well as confocal microscopy have the potential to assist the dermatologist in catching melanoma early on.

An ongoing study suggests total body digital photography could help reduce melanoma-related anxiety and worries for patients with atypical mole syndrome, says one of the study's authors.

In Australia, GPs and other non-specialists are effective in taking the heavy burden off the shoulders of dermatologists by sharing the work in seeing skin cancer patients. The problem is that some of these physicians lack special training and therefore c

Research at the gene expression level indicates that targeting the immune/inflammatory response could prove an effective approach in battling both intrinsic aging and photoaging, says a study co-author.

A retrospective five-year safety and efficacy study of a new PMMA filler shows a low risk of adverse events and a trend toward continued improvement over the entire five-year follow-up period, says a researcher involved with the study.

In a recent study of Chinese women, facial age spots have proven to be no predictor of facial wrinkling and vice versa, says a study author.

Future vitiligo treatments will largely target the immune system as well as promote the growth of melanocytes, according to the director of the Vitiligo and Pigmentation Institute of Southern California.

Dermatologists commonly turn to a variety of depigmenting agents and therapies for the treatment of melasma and post-inflammatory hyperpigmentation after acne, or traumatic scars and burns, according to Helen M. Torok, M.D., Medical Director, Trillium Creek Dermatology & Surgery, in Medina, Ohio.

A phase 2 study investigated the safety and efficacy of topical bexarotene 1 percent gel (Targretin, Eisai/Ligand) for treating alopecia areata. Hair regrowth of 50 percent or greater was achieved by 26 percent of patients.

Results from accumulating research suggest that gadolinium is a trigger for nephrogenic systemic fibrosis (NSF). Gadolinium exposure occurs through use of gadolinium-containing contrast agent (GCCA), and the type of GCCA may influence NSF risk. Further evidence is needed to verify these theories.

Seven newly identified sites of common DNA variations increase the risk for psoriasis and psoriatic arthritis. The whole genome association study of more than 300,000 single nucleotide polymorphisms (SNPs) was published in the March issue of PLoS Genetics. The goal was to identify new genes and new pathways for drug development.